Primary Job Title Auditor Primary Organization Braizon Therapeutics
Location Japan, Asia Regions Asia-Pacific (APAC) Gender Male Also Known As 竹内誠
Investor Type
At Yamanouchi and Astellas, engaged in drug discovery research in the areas of inflammation and bone metabolism, and created osteoporosis treatment minodronate and overactive bladder treatment solifenacin. After serving as Director of the Chemical Research Laboratory, Astellas Pharma Research Division, Executive Officer, Research Promotion
Division, and General Manager of the Research Management Division, he became Senior Executive Officer, External Relations Director. In addition, he has been involved in a wide range of industry activities, serving as the Research and Development Committee of the Japan Pharmaceutical Manufacturers Association, the chairman of the Industrial Policy Committee, and the Vice Chairman of the Regenerative Medicine Innovation Forum. He also studied at the University of Pennsylvania (Professor Amos B Smith III) for one year from 2001. Graduated from Toyama Medical and Pharmaceutical University Graduate School of Pharmacy. Lecturer at Seminar on Advanced Drug Discovery Science sponsored by the Pharmaceuticals Promotion Association
